Magnesium Rider in Clinical Context
A "rider" for magnesium refers to supplemental magnesium added to dialysis or parenteral nutrition solutions to prevent treatment-related hypomagnesemia and maintain appropriate serum magnesium levels during therapy.
Definition and Clinical Application
The term "rider" in this medical context describes electrolyte supplementation that "rides along" with the primary therapeutic solution—either kidney replacement therapy (KRT) fluids or parenteral nutrition (PN) formulations. This prevents iatrogenic electrolyte depletion that commonly occurs during these treatments.
In Kidney Replacement Therapy
Dialysis solutions containing magnesium should be used to prevent electrolyte disorders during KRT 1. The rationale is straightforward:
- Hypomagnesemia (serum Mg <0.70 mmol/L) occurs in up to 60-65% of critically ill patients on continuous kidney replacement therapy (CKRT)
- Magnesium is actively removed through both diffusive and convective clearance mechanisms
- When regional citrate anticoagulation is used, ionized magnesium becomes chelated by citrate and is lost in the effluent as magnesium-citrate complexes 1
The preferred strategy is prevention through modulated KRT fluid composition rather than intravenous supplementation, as exogenous supplementation carries risks and is more difficult to manage 1. Commercial KRT solutions enriched with magnesium are widely available and can be safely used as dialysis and replacement fluids, even with regional citrate anticoagulation.
In Parenteral Nutrition
For PN formulations, magnesium is usually administered as magnesium sulfate rather than magnesium chloride, as the chloride form increases the anion gap and raises the risk of metabolic acidosis 2.
Special consideration for neonates: Premature newborns exposed to maternal magnesium sulfate therapy (for preeclampsia or tocolysis) may have elevated magnesium levels in the first days of life. Their low postnatal glomerular filtration rates during the first week limit their ability to excrete excessive magnesium. Therefore, magnesium intakes must be limited and adapted to postnatal blood concentrations in these infants 2.
Key Clinical Pitfalls
- Do not rely on serum magnesium alone: Total blood magnesium concentration is not the best estimate of the biologically active fraction. Red blood cell magnesium (around 2.5 mmol/L) represents a better indicator of tissue magnesium content 2
- Reference ranges differ by age: Normal magnesium range for premature and term newborns during the first two weeks of life is 0.7-1.5 mmol/L, which is higher than adult values 2
- Avoid intravenous supplementation during CKRT: Use magnesium-containing dialysis solutions instead to prevent the complications associated with bolus supplementation 1
Physiological Importance
Magnesium is the fourth most abundant mineral in the body and the second most abundant intracellular cation. About one-third of blood magnesium is attached to plasma proteins, with the remaining two-thirds filtered by the kidney 2. Magnesium is essential for Mg-dependent adenyl-cyclase activity, which is involved in both PTH release and its activity on bone—thus, magnesium deficiency causes both deficient PTH release and peripheral PTH resistance, resulting in hypocalcemia 2.